Advert: researchsite_728x90
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: GoIndPfizerJan2010_300x250
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home > Industry News > World News
Hline
Advert: ABPIJan2010PT
LATEST WORLD NEWS Rss Feed    
FDA OKs wider use of AstraZeneca’s Crestor
Shares in AstraZeneca are on the rise this morning after US regulators gave the go-ahead for wider use of its blockbuster Crestor and allow it to be marketed as a preventative treatment for people who have normal or slightly elevated cholesterol levels

 Cost-cutting and emerging markets key for Europe's drugmakers
Now that four of the six European pharma majors have reported their fourth quarter and full-year financials (Sanofi will do so on Wednesday and Bayer on February 26), cost-cutting and emerging market growth are the two striking areas, according to analysts at Collins Stewart

 Alzheimer's drug Dimebon may help Huntington's patients
Medivation’s investigational Alzheimer’s disease drug Dimebon could benefit sufferers of Huntington's disease, according to a new study

 		Novartis buys rights to Debiopharm's hep C drug
Novartis has gained exclusive rights to develop a potential first-in-class hepatitis C treatment from fellow Swiss firm Debiopharm

 Study to look at earlier use of MS drug Tysabri
As regulators once again updated the label on Tysabri over the risk of a rare brain disease, Biogen Idec and Elan Corp are planning a trial that could lead to use of the MS blockbuster at the early stages of the condition

 AstraZeneca signs 'cancer metabolism' pact with charity
AstraZeneca is teaming up with Cancer Research UK in a deal that will focus on “the emerging field of cancer metabolism”
More Headlines
Arrow Teva settles US drug pricing lawsuits
Arrow Price rises "will drive US drug spend to $457.8 billion by 2019"
Arrow Putin sacks Russian drugs law critic
Arrow Japan can become a big business for GSK – Witty
Arrow GSK pipeline will give good returns on R&D spend – Witty
Arrow FDA wants more info on Protalix Gaucher drug
Arrow Roche enters into major stem cell pact
Arrow BioMarin bags PARP inhibitor with Lead Therapeutics buy
Arrow EC changes on running pharma must not be cosmetic – DTB
Arrow BREAKING NEWS: GSK coy on job loss numbers as new restructuring hits R&D
Arrow Takeda hurt by generic Prevacid but profit up
Arrow EU “pushing” India over generics in “secret” trade talks

Older >
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
LATEST JOBS
Arrow   UK Partnership Development Manager
Arrow   Account Manager
Arrow   Senior Account Manager/Account Manager Flexible Remote Home Working/Office
Arrow   Key Account Manager
Arrow   Business Manager - Oncology
Arrow   Safety Physicians – all levels
Arrow   European Head of Business Development
Arrow   GP/Hospital Representative
Arrow   Field Trainer
Arrow   Client Service Executive
line
flickrtwitteryoutube